Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.

Formosa Pharmaceuticals and Rxilient Medical have agreed on the commercialisation of APP13007 in ASEAN markets.

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.

On 1 December, the fortunes of the UK pharma sector changed radically, with the UK Government becoming the first in the world ...

AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.

Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.

With an eye on 2026, the healthcare editorial team reflects on key takeaways and trends from recent pharma conferences.

Citizen Health has entered a multi-year strategic partnership with UCB for expediting drug development across five rare ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

The UK becomes the latest country in President Donald Trump’s long line of trade agreements, though it is the first region to ...